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Abstract The objective of this study
was to examine the cerebral circula-
tion during spontaneous migraine
attacks and to compare changes to
an experimental headache model
induced by nitroglycerin (NTG)
infusion. This prospective study was
carried out in a tertiary care hospital
on migraineurs with or without
aura. Healthy volunteers served as
controls. There were no interven-
tions. Flow velocity (FV) and pul-
satility index (PI) were measured in
migraineurs between and during
headache attacks. In controls, FV
and PI of the middle cerebral arter-
ies were performed at baseline and
after each IV infusion of 0.125, 0.25
and 0.5 μg/kg/min of NTG. In
migraineurs, a significant increase
in the mean flow velocity (MFV) in
the left vertebral artery (VA) and the
PI of the right VA during sponta-
neous migraine headache was
found. In controls, all FV signifi-
cantly decreased after infusion of
NTG. The NTG model produces
expected and substantially different
vascular effects than those seen with
spontaneous migraine headache.
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Introduction
Transcranial Doppler (TCD) has often been used to inves-
tigate cerebral blood flow during migraine headache. The
mechanism underlying the pathogenesis of migraine is not
well understood and multiple hypotheses have been pro-
posed. Substantial data support the vascular hypothesis of
migraine pathogenesis [1]. In this model, the aura phase of
the migraine attack is ascribed to vasoconstriction in the
intracranial vasculature, with ensuing vasodilatation
thought to be the cause of the headache phase.
Past TCD studies were undertaken to determine blood
flow velocity (FV) as an indirect measurement of diame-
ters of the large intracranial arteries. These studies were
largely limited to velocity measurements from middle
cerebral arteries (MCA). The findings of these studies var-
ied, with reports of increased [2,3], decreased [2,4-10] or
unchanged velocities [11-13]. These discordant findings
have been attributed to technical limitations of TCD; as
only discrete segments of the vessel are insonated, opera-
tor dependent measurements, variability of migraine pre-
sentation, under sensitivity of limited number of vessels
insonated, and limitations of the vascular hypothesis.
Recently, attention has been directed to other calculat-
ed TCD parameters such as the pulsatility index (PI),
which is an index of vascular resistance. PI is a calculated
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value that has been found to reflect the distensibility of the
insonated vessel, and to be indicative of peripheral vascu-
lar resistance [14-16]. There is a paucity of published data
on the PI in migraine.
The relative unpredictability of the onset of migraine as
well as the inconvenience of transportation to study sites
has made study of spontaneous migraine difficult. To
address this, various experimental models have been pro-
moted including nitroglycerin (NTG), acetazolamide, iod-
inated contrast material, reserpine, red wine, cold pressor
challenge and mcpp [17-20]. Some models have the advan-
tage of providing a known time of insult onset and dura-
tion of pain. As with all models, it is important to deter-
mine how much it mimics the condition of interest.
Because of its vasodilatory properties, short half-life,
widespread clinical use and the ability to produce a pul-
satile headache, NTG has emerged as the most widely used
experimental model of migraine. Studies have shown that
NTG induces regional blood flow changes in the cerebral
vasculature that are similar to those seen in spontaneous
migraine [21]. Additionally, the emerging role of nitric
oxide (NO–) in pain mediation may indeed make NTG an
ideal model for migraine research. Moreover, it is found
that NTG has more responsiveness in migraine patients
compared to controls [22].
The primary objective of this study was to measure PI
and FV using TCD in multiple cerebral vessels in persons
with spontaneous migraine headache. The secondary
objective was to compare the results of MCA insonation
after NTG infusion in healthy volunteers with those
observed in persons with spontaneous migraine headache.
Materials and methods
All human studies have been reviewed by the appropriate ethics com-
mittee and performed in accordance with the ethical standards of the
1964 Declaration of Helsinki. All subjects signed informed consent
prior to their inclusion in the study, underwent physical examination
and electrocardiogram, and were screened with routine haemato-
chemical lab tests. The study was approved by the human use com-
mittee.
For inclusion, patients needed to be 18–65 years of age with a
minimum of one migraine attack per month (with or without aura,
diagnosed according to the International Headache Society criteria)
presenting within 24 h of the onset of a spontaneous migraine
headache.
Patients were excluded on the bases of clinically significant car-
diovascular, central nervous system or psychiatric disease. Patients
who received vasoconstrictors, opiates (within 72 h of study), pro-
phylactic migraine medications within one month or simple analgesic
medications within six hours of study were excluded as well.
Nonsmoking healthy volunteers 18–45 years of age were recruit-
ed as controls. Exclusions were decided on the basis of personal or
family history of migraine headache, and clinically significant cardio-
vascular, central nervous or psychiatric disorders.
TCD was performed using the same device in both cases and con-
trols; however control subjects for the NTG study underwent bilater-
al insonation of the MCA only. Baseline measurements were
obtained, and then followed by IV NTG infusions at 0.125, 0.25 and
0.5 μg/kg/min for approximately 15 min at each level. Measurements
were made at the end of each dosing interval.
TCD (Neuroguard, Fremont, CA) studies were performed by the
same experienced technician at the Veterans Administration Medical
Center, Buffalo, NY. Blood FV was measured during a migraine
headache in the right and left MCAs, right and left vertebral arteries
(VAs), and the basilar artery (BA). Participants returned for the same
measurements following a spontaneous headache-free interval of at
least 48 h.
Gosling’s PI [23] was calculated automatically by the Doppler
machine using the formula: (PSV–EDV)/MV (peak systolic veloci-
ty–end diastolic velocity)/mean velocity
Statistics
Student’s t-test was applied. The level of significance was set as
α=0.05. Systat® was used for all comparisons.
Results
Ten migraineurs (four males and six females) and 12 volun-
teers (six males and six females) were enrolled in the respec-
tive studies. Characteristics of these populations are given in
Table 1.
TCD measurements from migraineurs during the
headache and the headache-free periods are listed in Table 2.
Amongst migraineurs, velocity changes were variable.




Migraine type (with aura/without 4/5/1 NA
aura/both)
Headache side R/L/bilateral 7/2/1 NA
Headache started (hours before test)* 9.5 (7.6) NA
Age (years)* 38.9 (12.3) 27.75 (9.06)




When compared to the headache-free measurements, a statis-
tically significant increase in the mean flow velocities
(MFV) was observed in the left VA (p=0.043). The mean
velocity (MV) in the right VA increased as well, but it failed
to reach statistical significance (p=0.067). Headache PI mea-
surements changed significantly in only the right VA
(p=0.019) (Tables 1 and 2).
The velocity measurements in healthy volunteers partici-
pating in the NTG study are given in Table 3. Consistent and
significant decreases in velocities were observed following
each dose of NTG infusion. PI measurements were
unchanged significantly (Table 3).
Discussion
Consistent with many TCD studies [2-13], this study detect-
ed no significant change in FV in the MCAs in patients with
migraine during the headache phase. The lack of significant
FV changes during the headache phase of migraine as
explored by TCD has been explained by several theories
including the various technical limitations of TCD [16].
TCD is a blind procedure and due to that, the angle of
insonation is not always optimal, it is operator-dependent
and it measures only a short span of cardiac cycles. Also it
insonates only a small segment of the vessel at any given
time. Our study has a small sample size, and migraine with
and without aura were mixed in the same group. A homoge-
neous and a much larger sample size may be needed to fully
answer this question. Also, the size and calibre of the VAs in
each subject in our study were not checked, a factor that
could have influenced the asymmetry in TCD findings.
The two significant findings in this study were the
increase in the mean blood FV in the left VA and the decrease
in the PI of the right VA during the headache phase of
migraine.
The decreased PI is usually an indirect indication of a
decreased upstream vascular resistance, which in turn would
cause an increase in mean blood FV inside the insonated seg-
ment (this was actually observed in both VAs in our study
although it was not statistically significant on the right). As
the above measurements took place during the headache
phase of migraine, the finding may very well support the
presence of a posterior cerebral circulation small vessel
dilatation as a primary or secondary phenomenon during the
headache phase of migraine.
The mild asymmetry in flow and the PI measurements
observed over the right and left VAs in our study could very
well be due to the higher frequency of right-sided headache in
our migraineur group (8/2). If this is the reason, then we spec-
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Table 2 TCD measurements in migraineur
Headache free Headache Change
Mean velocitya
RMCA 62.90 (17.86) 55.45 (14.39) –7.45
LMCA 64.63 (15.44) 61.90 (17.73) –2.73
RVERT 33.27 (9.98) 33.81 (6.06) +0.54
LVERT** 35.54 (4.43) 37.81 (4.75) +2.27
BA 40.36 (9.44) 39.09 (10.56) –1.27
Peak velocitya
RMCA 90.16 (19.0) 87.22 (20.9) –2.94
LMCA 96.10 (17.7) 92.91 (26.5) –3.19
RVERT 47.69 (9.8) 50.90 (10.6) +3.21
LVERT 48.28 (5.6) 54.98 (9.5) +6.70
BA 58.88 (12.57) 57.98 (14.5) –0.9
PI
RMCA 0.79 (0.1) 0.73 (0.2) –0.06
LMCA 0.76 (0.1) 0.70 (0.1) –0.06
RVERT* 0.74 (0.2) 0.66 (0.1) –0.08
LVERT 0.68 (0.1) 0.67 (0.1) –0.01
BA 0.70 (0.1) 0.69 (0.1) –0.01
acm/s, mean (SD); *p=0.017, **p=0.046
Table 3 Healthy volunteers TCD with NTG infusion
PI Baseline 0.125 μg/kg/min 0.25 μg/kg/min 0.5 μg/kg/min
RMCA 0.71 (0.12) 0.68 (0.13) 0.67 (0.15) 0.64 (0.13)
LMCA 0.69 (0.08) 0.66 (0.06)* 0.65 (0.13) 0.64 (0.11)
Peak
RMCA 98.83 (15.96) 82.67 (6.99)* 78.33 (12.56)* 78.58 (14.29)*
LMCA 94.58 (16.41) 80.17 (10.89)* 79.58 (8.53)* 74.92 (10.87)*
Mean
RMCA 69.00 (12.76) 58.50 (9.77)* 54.83 (7.93)* 55.08 (8.64)*
LMCA 66.83 (12.03) 57.83 (8.31)* 56.08 (6.01)* 53 (7.25)*
*p<0.05
ulate that the medulla and/or lower pons may be involved in
the genesis of migraine as both VAs usually join rostral to
lower pons to form the BA and factors that affect flow after
that point should result in flow changes in both VAs. Statistical
analysis on patients with only right-sided headaches showed
higher statistical significance of the MFV of the left VA
(p=0.029). However, PI change remains insignificant. This
may also be due the small number of subjects in our study.
In our previous positron emission tomography study of
cerebral blood flow in migraineurs [21], we observed signif-
icant decreases in blood flow in the posterior brain region
during the headache phase. This cannot be explained by the
peripheral vasodilatation and increased blood FV noted in
this region in this study. One possible intriguing interpreta-
tion that we can offer here is the existence of micro-arteri-
ovenous malformations that shunt blood away from their tar-
get. The presence of arteriovenous shunts in that region in
migraineurs has been documented and their role in migraine
headache has been postulated [24].
Taking the significant increase in FV in the left VA alone,
one can interpret this finding as vasoconstriction of the left
VA that increases the blood FV without affecting PI. It is pos-
sible that vasoconstriction of the posterior circulation is the
reason for some of the symptoms of the migraine aura, attack
or the postdromal phase. For example, frequent migraine his-
tory has been reported in cases of VA dissections [25]; even
strokes and white matter lesions in the posterior circulation
distribution were found to be more common in people with
migraine [26].
The triggers that caused our findings, and whether our
findings are the cause or a result remain unclear. Perhaps
more emphasis should be put on the posterior circulation in
migraine research, especially as the posterior circulation dif-
fers in its autonomic innervation, which renders it more vul-
nerable to subtle changes in flow [27, 28].
All TCD findings of FVs in the experimental NTG study
were in accordance with the expected vasodilatation induced
by NTG. The increase in FV is an indirect indication of the
generalised vasodilatation effect of NTG. These changes,
however, are remarkably different to those observed in the
same vessels in spontaneous migraine headache. This ques-
tions the validity of healthy volunteers receiving NTG as a
migraine headache model in migraine research.
A limitation of our study may be the low sample size and
that we did not differentiate between migraine with and with-
out aura, which may have different mechanisms of action or
haemodynamic effects. A larger sample size and/or a more
homogeneous  sample comparing only migraine with aura or
migraine without aura may have led to more precise findings.
Also, we did not retrospectively ask when the last migraine
attack of our migraineurs occurred, a factor that may be of
significance if haemodynamic effects of the migraine
extended for longer than the inclusion/exclusion criteria
time-after-attack required.
Conclusions
In spontaneous migraine headache, TCD measurements of
FVs and PIs do not change in a manner consistent with a sim-
ple, generalised, intracranial vasodilatation. Rather, TCD
measurements indicate the presence of significant asymmet-
rical changes in the VAs during a spontaneous migraine
headache attack. The exact role of this finding needs to be
further investigated.
NTG infusion induces predicted changes in TCD para-
meters in healthy volunteers. The changes in the cerebral
blood flow following NTG infusion do not resemble those
seen during the migraine headache attack.
References
1. Wolff HG (1963) Headache and other
headache pain. New York, NY: Oxford
University Press Inc. 1–688
2. Thie A, Fuhlendorf A, Spitzer K,
Kunze K (1990) Transcranial Doppler
evaluation of common and classic
migraine, part II: ultrasonic features
during attacks. Headache 30:209–215
3. Abernathy M, Donnelly G, Kay G et al
(1994) Transcranial Doppler sonogra-
phy in headache-free migraineurs.
Headache 34:198–203
4. Friberg L, Olesen J, Iversen HK,
Sperling B (1991) Migraine pain asso-
ciated with middle cerebral artery
dilatation: reversal by sumatriptan.
Lancet 338:13–17
5. Zanette EM, Angoli A, Roberti C et al
(1992) Transcranial Doppler in sponta-
neous attacks of migraine. Stroke
23:680–685
6. Totaro R, De Matteis G, Marini C,
Prencipe M (1992) Cerebral flood flow
in migraine with aura: A transcranial
Doppler sonography study. Headache
32:446–451
7. Zwelsloot CP, Caekebeke JF, Jansen
JC et al (1991) Blood flow velocity
changes in migraine attacks – a tran-
scranial Doppler study. Cephalalgia
11:244
8. Pierelle F, Pauri F, Cupini LM et al
(1991) Transcranial Doppler study in
familial hemiplegic migraine.
Cephalalgia 11:29–31
9. Thomsen LL, Iversen HK, Olesen J
(1995) Cerebral blood flow velocities
are reduced during attacks of unilateral




10. Totaro R, Matteis GD, Marini C et al
(1997) Sumatriptan and cerebral blood
flow velocity changes during migraine
attacks. Headache 37:635–639
11. Zwetsloot CP, Caekebeke JFV, Ferrari
MD (1993) Lack of asymmetry of
cerebral artery blood velocity in unilat-
eral migraine. Stroke 24:1335–1338
12. Pavy Le Traon A, Cesari JB, Faber N
et al (1989) Contribution of transcra-
nial Doppler to the study of cerebral
circulation in the migraineur. N Adv H
R 157–161
13. Zwetsloot CP, Caekebeke JF, Jansen
JC et al (1992) Blood flow velocities
in the vertebrobasilar system during
migraine attacks- a transcranial
Doppler study. Cephalalgia 12:29–32
14. Legarth J, Nolsoe C (1990) Doppler
blood velocity waveforms and the rela-
tion to peripheral resistance in the
brachial artery. J Ultrasound Med
9:449–453
15. Legarth J, Thorup E (1998)
Characteristics of Doppler blood veloc-
ity wave forms in a cardiovascular, in
vitro model II; the influence of periph-
eral resistance, perfusion pressure, and
blood flow. Scand J Clin Lab Invest
49:459–464
16. Kassab MY, Majid A, Farooq MU et al
(2007) Transcranial Doppler: an intro-
duction for primary care physicians. J
Am Board Fam Med 20:65–71
17. Krabbe A, Olesen J (1980) Headache
provocation caused by continuous
intravenous infusion of histamine.
Pain 8:253–259
18. Iversen HK (1995) Experimental head-
che in humans. Cephalalgia
15:281–287
19. Littlewood JT, Gibb C, Glover V et al
(1988) Red wine as a cause of
migraine. Lancet  I:1104–1106
20. Iversen HK, Olesen J, Tfelt-Hansen P
(1989) Intravenous nitroglycerin as an
experimental model of vascular
headache. Basic characteristics.
Pain 38:17–24
21. Bednarczyk EM,  Wack DS,  Kassab
MY et al (2002) Brain blood flow in
the nitroglycerin (GTN) model of
migraine: measurement using positron
emission tomography and transcranial
Doppler. Cephalalgia 22:749–757
22. Zanette EM, Agnoli A, Cerbo R et al
(1991) Transcranial Doppler (TCD)
after nitroglycerin in migraine without
aura. Headache 31:596–598
23. Gosling RG, King DH (1974) Arterial
assessment by Doppler shift ultra-
sound. Proc R Soc Med 67:447–449
24. Saxena PR (1978) Arteriovenous
shunting and migraine.  Res Clin Stud
Headache 6:89–102
25. Tzourio C, Benslamia L, Guillon B et
al (2002) Migraine and the risk of cer-
vical artery dissection: a case-control
study.  Neurology 59:435–437
26. Kruit MC, Van Buchem MA, Hofman
PA et al (2004) Migraine as a risk fac-
tor for subclinical brain lesions. JAMA
291:427–434
27. Edvinsson L, Owman C (1977)
Sympathetic innervation and adrener-
gic receptors in intraparenchymal cere-
bral arterioles of baboon.  Acta Physiol
Scand [Suppl] 452:57–59
28. Chen X, Sun B, Zhong S (1988)
Nerves accompanying the vertebral
artery and their clinical relevance.
Spine 13:1360–1364
